Islet cell transplantation in type 1 diabetes: An analysis of efficacy outcomes and considerations for trial designs

American Journal of Transplantation

Volumn 12, Issue 7, 2012, Pages 1898-1907

  Tiwari, Jawahar L ^a   Schneider, B ^a   Barton, F ^b   Anderson, S A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b EMMES CORPORATION   (United States)

Author keywords

Clinical efficacy; Clinical trials; Islet transplantation; Kaplan Meier survival analysis; Sample size; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; REGISTRIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84863198439     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04038.x     Document Type: Article

References (8)

1. U.S. Food and Drug Administration. 2008. Guidance for Industry: Considerations for Allogenic Pancreatic Islet Cell Products. http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/default.htm. accessed on 1/30/2011.
2. Collaborative Islet Transplant Registry (CITR) Fifth Annual Report 2008. www.citregistry.org.
3. Anderson JR, Cain JC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol 1983; 1: 710-719. (Pubitemid 14202071)
4. JMP Version 7.0 Software, SAS Institute Inc. Cary, NC.
5. Cytel Studio 8 Software, CYTEL Software Corporation, Cambridge, MA 02139.
6. U.S. Food and Drug Administration. 2010. Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics. Draft Guidance. http://www.fda.gov/downloads/Drugs/guidance complianceregulatoryinformation/ guidances/ucm201790.pdf
7. The Prevention and Treatment of Missing Data in Clinical Trials. Panel on Handling Missing Data in Clinical Trials. Committee on National Statistics, Division of Behavioral and Social Sciences and Education, Washington, DC: The National Academy Press, 2010.
8. Alejandro R, Barton FB, Hering B, Rickels M, Berney T, Pattou F, Shapiro AMJ and the CITR Investigators. Predictiveness of positive C-peptide for outcomes of islet transplantation. Xenotransplantation 2009; 16: 293.